Pleryon Therapeutics

Developer of drug delivery and biomaterials technologies

placeShenzhen, Guangdong Province, China calendar_todayFounded 2017 language pleryon.com

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 27 times.

YearFilings
20211
20231
20241
20252
20261

Social engagement

Social engagement: 180 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Efung Capital.

Investor typeCountShare
Private equity1100%
Coming soon